Pharmaceutical Executive: What is the future of field reps and their relationship with AI? Parth Khanna: Based on our ...

Taken together, Hill's response suggests that restricting access through legitimate compounding channels, without addressing ...

Pharma has more competitive data than ever — and is still getting surprised. Lifescience Dynamics on why intelligence requires human judgment. Pharmaceutical companies have never had access to more ...

President Donald Trump’s administration is preparing to announce a new round of drug-pricing agreements with midsize biotech ...

FDA approved Priovant's Lisraya (brepocitinib) as the first targeted therapy for dermatomyositis, Gilead's Bixlenvo as the ...

Eli Lilly and Company announced results from a real-world study of adults over 55 with obesity or overweight showing that ...

Osivax and GC Biopharma team up on a next-generation flu vaccine, K2 Therapeutics' Ying Huang talks through why so few drugs ...

ACTO CEO Parth Khanna on why sales reps still matter — and how human intelligence plus empathetic agents is the winning formula for field teams.

FDA approves Imaavy as the first treatment for warm autoimmune hemolytic anemia, McKesson agrees to acquire Precision ...

With biopharma batch failures averaging every 40 weeks, predictive maintenance and connected monitoring are becoming critical ...

The FDA has approved daraxonrasib (brand name Rasonque) for adults with metastatic pancreatic adenocarcinoma who have ...

A new Eli Lilly study links Zepbound to lower healthcare costs in older adults with obesity, Biohaven and Haisco strike major ...